These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3207620)

  • 1. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered keratin expression in benign and malignant skin diseases revealed with monoclonal antibodies.
    Kariniemi AL; Virtanen I
    Am J Dermatopathol; 1989 Jun; 11(3):202-8. PubMed ID: 2471415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bowen's disease of the umbilicus simulating psoriasis vulgaris.
    Kolbusz RV; Fretzin DF
    Cutis; 1988 Oct; 42(4):321-2. PubMed ID: 3234030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.
    Nanney LB; Stoscheck CM; Magid M; King LE
    J Invest Dermatol; 1986 Mar; 86(3):260-5. PubMed ID: 3018088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
    Kawakami T; Soma Y; Mizoguchi M; Saito R
    Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichilemmal tumor arising in a seborrheic keratosis: analysis of cell kinetics by BrdU staining.
    Kitagawa K; Amagai M; Miyakawa S; Hayakawa K; Ueda M; Shimizu N
    J Dermatol; 1991 Jun; 18(6):334-9. PubMed ID: 1719052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ localization of S-phase-specific histone (H3) mRNA in Bowen's disease.
    Murakami M; Mizoguchi Y; Horibe Y; Komori K; Hori H; Kasahara M
    APMIS; 1999 Nov; 107(11):1005-12. PubMed ID: 10598872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis.
    Higashiyama M; Hashimoto K; Matsumoto K; Yoshikawa K
    J Dermatol Sci; 1994 Feb; 7(1):45-53. PubMed ID: 7514888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of centriole duplication in human epidermis, Bowen's disease, and squamous cell carcinoma.
    Watanuki S; Fujita H; Kouyama K; Amagai M; Kubo A
    J Dermatol Sci; 2018 Jul; 91(1):9-18. PubMed ID: 29615326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of the epidermal-dermal junction and cutaneous basal lamina in Bowen's disease.
    Warfel KA; Hull MT
    J Cutan Pathol; 1989 Aug; 16(4):203-6. PubMed ID: 2794163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis.
    Otsuka F; Shima A; Ishibashi Y
    Cancer; 1989 Mar; 63(5):891-6. PubMed ID: 2914295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light microscopic autoradiographical analysis of [125I]epidermal growth factor binding in basal cell epithelioma and squamous cell carcinoma of the skin.
    Ikeuchi T; Urano Y; Fukuhara K; Nakanishi H; Arase S
    J Dermatol; 1993 Apr; 20(4):219-25. PubMed ID: 8315111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
    Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
    Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological assessment of localized proliferation in cases of Bowen's disease using immunostaining and a laser cytometer.
    Murakami M; Hashimoto Y; Tsukinoki K; Matsunaga K; Mizoguchi Y; Horibe Y; Tashiro K; Watanabe Y; Kasahara M
    Arch Dermatol Res; 1998 Aug; 290(8):435-40. PubMed ID: 9763306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrhoeic keratosis, Bowen's disease and basal cell carcinoma.
    Morimoto Y; Saga K; Bando M; Takahashi M
    Br J Dermatol; 1991 Jul; 125(1):9-13. PubMed ID: 1831385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.